Last updated on January 2019

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)


Brief description of study

The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.

Clinical Study Identifier: NCT02887495

Contact Investigators or Research Sites near you

Start Over

Victoria K Shanmugam

Washington, WA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.